nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.144	0.166	CbGbCtD
Ketobemidone—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0921	0.106	CbGbCtD
Ketobemidone—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0921	0.106	CbGbCtD
Ketobemidone—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0832	0.0956	CbGbCtD
Ketobemidone—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0766	0.088	CbGbCtD
Ketobemidone—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0766	0.088	CbGbCtD
Ketobemidone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0588	0.0675	CbGbCtD
Ketobemidone—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0581	0.0667	CbGbCtD
Ketobemidone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0397	0.0456	CbGbCtD
Ketobemidone—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0387	0.0445	CbGbCtD
Ketobemidone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0379	0.0435	CbGbCtD
Ketobemidone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0338	0.0388	CbGbCtD
Ketobemidone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0198	0.0228	CbGbCtD
Ketobemidone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0187	0.0215	CbGbCtD
Ketobemidone—Pethidine—SLC6A4—chronic obstructive pulmonary disease	0.0025	0.655	CrCbGaD
Ketobemidone—Pethidine—ALB—chronic obstructive pulmonary disease	0.00132	0.345	CrCbGaD
Ketobemidone—OPRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000119	0.000942	CbGpPWpGaD
Ketobemidone—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000118	0.000936	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000117	0.000928	CbGpPWpGaD
Ketobemidone—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000116	0.000923	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000116	0.000922	CbGpPWpGaD
Ketobemidone—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000114	0.000909	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000113	0.000898	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000113	0.000898	CbGpPWpGaD
Ketobemidone—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000113	0.000897	CbGpPWpGaD
Ketobemidone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.000897	CbGpPWpGaD
Ketobemidone—OPRM1—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.000113	0.000896	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.000891	CbGpPWpGaD
Ketobemidone—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.000887	CbGpPWpGaD
Ketobemidone—OPRM1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000111	0.000878	CbGpPWpGaD
Ketobemidone—OPRK1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.00011	0.000876	CbGpPWpGaD
Ketobemidone—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.000875	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—GC—chronic obstructive pulmonary disease	0.00011	0.000874	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000109	0.000869	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000108	0.000858	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	0.000106	0.000843	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000106	0.000841	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000105	0.000836	CbGpPWpGaD
Ketobemidone—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000105	0.000835	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000104	0.000829	CbGpPWpGaD
Ketobemidone—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000104	0.000829	CbGpPWpGaD
Ketobemidone—UGT1A9—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000104	0.000826	CbGpPWpGaD
Ketobemidone—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000104	0.000824	CbGpPWpGaD
Ketobemidone—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000103	0.000818	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000102	0.000812	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.0001	0.000794	CbGpPWpGaD
Ketobemidone—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.97e-05	0.000792	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.93e-05	0.000789	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.92e-05	0.000788	CbGpPWpGaD
Ketobemidone—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.84e-05	0.000781	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.82e-05	0.00078	CbGpPWpGaD
Ketobemidone—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.59e-05	0.000762	CbGpPWpGaD
Ketobemidone—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	9.58e-05	0.000761	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	9.56e-05	0.000759	CbGpPWpGaD
Ketobemidone—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.46e-05	0.000751	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	9.46e-05	0.000751	CbGpPWpGaD
Ketobemidone—OPRM1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	9.32e-05	0.00074	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.25e-05	0.000734	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.22e-05	0.000732	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.14e-05	0.000726	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	9.14e-05	0.000726	CbGpPWpGaD
Ketobemidone—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.09e-05	0.000722	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	8.99e-05	0.000714	CbGpPWpGaD
Ketobemidone—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.97e-05	0.000712	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	8.97e-05	0.000712	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	8.91e-05	0.000708	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	8.77e-05	0.000696	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.34e-05	0.000662	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.29e-05	0.000658	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.25e-05	0.000655	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.15e-05	0.000647	CbGpPWpGaD
Ketobemidone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.14e-05	0.000646	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	8.09e-05	0.000643	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	8.02e-05	0.000637	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7.97e-05	0.000632	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	7.82e-05	0.000621	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.62e-05	0.000605	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.62e-05	0.000605	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.41e-05	0.000589	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	7.32e-05	0.000581	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.23e-05	0.000574	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	7.1e-05	0.000564	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.03e-05	0.000558	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.01e-05	0.000556	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.98e-05	0.000555	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.97e-05	0.000553	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.88e-05	0.000547	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	6.84e-05	0.000543	CbGpPWpGaD
Ketobemidone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.79e-05	0.000539	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.68e-05	0.000531	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	6.68e-05	0.00053	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.64e-05	0.000527	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.61e-05	0.000525	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.41e-05	0.000509	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.36e-05	0.000505	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.34e-05	0.000504	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.33e-05	0.000502	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.33e-05	0.000502	CbGpPWpGaD
Ketobemidone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.24e-05	0.000495	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.11e-05	0.000485	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.01e-05	0.000477	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6e-05	0.000476	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6e-05	0.000476	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.95e-05	0.000473	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	5.94e-05	0.000472	CbGpPWpGaD
Ketobemidone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.92e-05	0.00047	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.91e-05	0.000469	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.9e-05	0.000469	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	5.79e-05	0.00046	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.72e-05	0.000454	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.65e-05	0.000449	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.65e-05	0.000448	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.57e-05	0.000443	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.55e-05	0.000441	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.54e-05	0.00044	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	5.42e-05	0.00043	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.39e-05	0.000428	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.36e-05	0.000426	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.32e-05	0.000422	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.27e-05	0.000419	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.22e-05	0.000414	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.18e-05	0.000411	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	5.17e-05	0.000411	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.16e-05	0.00041	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.99e-05	0.000397	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.9e-05	0.000389	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.89e-05	0.000388	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.85e-05	0.000385	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.84e-05	0.000385	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.83e-05	0.000383	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.81e-05	0.000382	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.81e-05	0.000382	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.78e-05	0.00038	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	4.71e-05	0.000374	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.69e-05	0.000372	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.54e-05	0.000361	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.52e-05	0.000359	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.42e-05	0.000351	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.38e-05	0.000348	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.31e-05	0.000342	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.29e-05	0.000341	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.27e-05	0.000339	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.19e-05	0.000333	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.17e-05	0.000331	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.13e-05	0.000328	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.11e-05	0.000326	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.07e-05	0.000323	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.91e-05	0.00031	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.88e-05	0.000308	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.84e-05	0.000305	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.83e-05	0.000304	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.83e-05	0.000304	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.77e-05	0.0003	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.75e-05	0.000298	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.74e-05	0.000297	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.74e-05	0.000297	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	3.69e-05	0.000293	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.63e-05	0.000288	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.54e-05	0.000281	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.49e-05	0.000277	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.48e-05	0.000276	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.43e-05	0.000272	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.41e-05	0.00027	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.4e-05	0.00027	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	3.37e-05	0.000268	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.35e-05	0.000266	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.28e-05	0.00026	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.2e-05	0.000254	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.19e-05	0.000253	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.17e-05	0.000251	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.16e-05	0.000251	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	3.13e-05	0.000248	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.12e-05	0.000248	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.11e-05	0.000247	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.11e-05	0.000247	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.05e-05	0.000242	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.96e-05	0.000235	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.92e-05	0.000232	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.9e-05	0.00023	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.89e-05	0.00023	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.88e-05	0.000229	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.86e-05	0.000227	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.85e-05	0.000227	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.82e-05	0.000224	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.79e-05	0.000222	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.77e-05	0.00022	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.73e-05	0.000217	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.63e-05	0.000209	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.6e-05	0.000207	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.6e-05	0.000207	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.59e-05	0.000206	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.58e-05	0.000205	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.58e-05	0.000204	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.56e-05	0.000203	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	2.55e-05	0.000202	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.55e-05	0.000202	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.51e-05	0.000199	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	2.47e-05	0.000196	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.39e-05	0.00019	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.38e-05	0.000189	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.37e-05	0.000188	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.36e-05	0.000187	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.35e-05	0.000186	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.32e-05	0.000184	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.31e-05	0.000183	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.28e-05	0.000181	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.26e-05	0.000179	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.2e-05	0.000174	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.19e-05	0.000174	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.16e-05	0.000172	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.14e-05	0.00017	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.12e-05	0.000168	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.09e-05	0.000166	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.03e-05	0.000161	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.02e-05	0.00016	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.02e-05	0.00016	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	2.01e-05	0.00016	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.96e-05	0.000155	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.93e-05	0.000153	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.93e-05	0.000153	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.93e-05	0.000153	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.92e-05	0.000153	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.91e-05	0.000152	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.88e-05	0.000149	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.83e-05	0.000145	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.8e-05	0.000143	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.79e-05	0.000142	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.76e-05	0.00014	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.72e-05	0.000137	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.71e-05	0.000136	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.71e-05	0.000135	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.7e-05	0.000135	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.69e-05	0.000134	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.68e-05	0.000133	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.64e-05	0.000131	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.64e-05	0.00013	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.63e-05	0.000129	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.56e-05	0.000123	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.55e-05	0.000123	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	1.53e-05	0.000122	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.53e-05	0.000122	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.51e-05	0.00012	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.48e-05	0.000118	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.47e-05	0.000117	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.42e-05	0.000113	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.41e-05	0.000112	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.39e-05	0.00011	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.3e-05	0.000103	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.3e-05	0.000103	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.28e-05	0.000101	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.25e-05	9.93e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.24e-05	9.87e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.24e-05	9.87e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.18e-05	9.35e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.16e-05	9.22e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	1.16e-05	9.21e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.14e-05	9.03e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	1.11e-05	8.81e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.08e-05	8.59e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.06e-05	8.39e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.05e-05	8.34e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.03e-05	8.14e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.01e-05	8.03e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.61e-06	7.63e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.97e-06	5.54e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.67e-06	5.3e-05	CbGpPWpGaD
